1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Chin,2005,55:74 - 108.
2Gonzalez FJ, Yu AM. Cytochrome P450 and xenobiotic receptor humanized mice[ J]. Annu Rev Pharmacol Toxicol,2006,46:41 --64.
3Yang CX, Matsuo K, Wan ZM, et al. Phase Ⅰ / Ⅱ enzyme gene polymorphisms and esophageal cancer riks: a meta-analysis of the literature[ J]. World J Gastroentero1,2005,11 ( 17 ) :2531 - 2538.
4Yang M, Claoi Y, Hwangbo BM, et al. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility[ J ]. Lung Cancer,2007,57 (2) : 135 - 142.
5Jonsson S, Thorsteinsdottir U, Gudbhartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population [ J ]. AMA, 2004,292:2977 - 2983.
8Larsen JE, Colosimo ML, Yang IA, et al. Risk of non-small cell lung cancer and the cytochrome P-4501A1 Ile462 Val ploymor-phism[ J]. Cancer Causes Control,2005,16 (5) :579 - 585.
9Masson LF,Sharp L,Cotton SC,et al. Cytochrom P4501A1 gene polymorphisms and risk of breast cancer:a HuGE review[ J]. Am J Epidemiol,2005,161 (10) :901 -915.
10Seremak-Mrozikiewica A,Drews K,Semczuk A,et al. CYP1A1 aIleles in female genital cancers in the Polish population[J]. Fur J Obstet Gynecol Reprod Biol,2005,118(2) :246 -250.
